The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandeep Reddy Kommidi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Sandeep Reddy Kommidi, a non-promoter shareholder, has sold his entire holding of 27,56,500 equity shares (7.45%) in Oxygenta Pharmaceutical Ltd on May 12, 2025. The transaction was executed off-market as per a Memorandum of Understanding dated September 30, 2024. Post-sale, his holding in the company stands reduced to Nil. The company's total equity share capital remains unchanged at 3,69,83,500 shares of Rs. 10 each.
This is a complete exit by a non-promoter shareholder via an off-market, MOU-based transfer, so it is unlikely to cause direct selling pressure on the stock. However, retail investors should note that a 7.45% stake has changed hands privately, and it may be worth tracking who the buyer is and the price at which this block deal was struck.